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 Supplementary Figure 1 
Extended Schematic for Multiplexed-CREATE and Analysis of Round-1 Selection. 
a, Diagram of the genetic switch used in M-CREATE. The Acceptor Vector shows the position of the forward and reverse primers 
between the Lox sites that are used for selective recovery of capsids from the Cre+ cells. The Rep-AAP∆Cap vector shows a deletion of 
480 bp in cap gene in addition to the stop codons that are designed to prevent synthesis of VP1, VP2, and VP3 proteins. AAP protein 
translation is unaffected by these modifications. b, Schematic of the protocol to selectively recover rAAV genomes from the target 
population using the Cre-Lox flipping strategy and preparation of the sample for deep sequencing. c, The library coverage for R1 DNA 
and virus libraries obtained from specific sequencing depths. d, The percentage of variant overlap within the sampled DNA and virus, or 
across different Cre lines within tissues, or across tissues from R1 selection. e, The distributions of AAV capsid read counts for libraries 
recovered by NGS from brain tissue across different Cre transgenic mice post R1 selection. The dotted line is illustrative only and 
roughly separates the signal from noise (see Methods for estimation of signal v.s. noise) where signal in this context represents the 
input for the R2 selection. f, rAAV genome recovery from tissues using different treatments are shown with total rAAV genome recovery 
from 0.1 g of liver, g, Percentage of rAAV genomes recovered per ng of total extracted DNA, and h, The CT value (cycle threshold from 
qPCR) of rAAV genome extracted by trizol that were treated with SmaI restriction enzyme or untreated and i, CT value of mitochondrial 
DNA (internal control for smaller genome recovery, fold change = 10.79 (2ΔCT)) recovered from 1 ng of total DNA from liver tissue. In f-i, 
n = 4 mice; 2 from GFAP-Cre line and 2 from Tek-Cre line, each data point is drawn from the mean of three technical replicates, error 
bar is mean±S.E.M., Mann-Whitney test, two-tailed (exact P-value of 0.0286 (*P ≤ 0.05), in f, g, i, and 0.1143 (n.s., P > 0.05, CI 95%)  
in h). The data reported f, g, i are from one independent trial, and h, from three independent trials. 
 Supplementary Figure 2 
Analysis of 7-mer-i rAAV Libraries From Round-2 Selections. 
a, The vector yields obtained per 10 ng of capsid DNA library across R1 and R2 vector productions. b, Distributions of the DNA and 
virus libraries produced by the synthetic pool and PCR pool methods by the standard score of NGS read counts. The variants in virus 
libraries are sorted by the decreasing order of standard score and their scores from respective DNA libraries are mapped onto them. c, 
Correlations between the standard scores of read counts for the DNA and virus libraries (n = 1 per library) produced by the synthetic 
pool and PCR pool methods is determined by linear least-squares regression, and the regression line (best fit) and R2 representing the 
coefficient of determination is shown. d, Distributions of capsid libraries from brain tissue of two mice (purple and green) used in each 
Cre line selection, as produced by the synthetic pool (left) and PCR pool (right) designs. The distribution of spike-in library introduced in 
the synthetic pool library design is shown in red (center). e, Correlations of enrichment scores of variants from the brain libraries (n = 2 
per Cre line, mean is plotted) produced by synthetic pool and PCR pool methods is determined by the same method described in c.  
 Supplementary Figure 3 
Analysis of Round-2 7-mer-i Tissue Libraries From Synthetic Pool And PCR Pool Methods. 
a, Correlation analysis between the enrichment score (log10) of two alternate codon replicates of variants from the GFAP-Cre (left), 
SNAP-Cre (center), and Syn-Cre (right) brain libraries by linear least-squares regression (n = 2 per Cre line, mean is plotted). The 
dotted line separates the high-confidence signal from noise. High confidence signal (below) is assessed by a linear regression line (best 
fit) and R2 represents the coefficient of determination. b, The difference in enrichment score between the two codon replicates of a 
variant, across different brain libraries, with over 8000 variants recovered in replicates. c, Heatmaps represent the magnitude (log2 fold 
change) of AA bias in “output” library 1 normalized to “input” library 2 that reach statistical significance (boxed if P-value ≤ 0.0001, two-
sided, two-proportion z-test, except in R1 DNA normalized to known NNK template where one-proportion z-test was performed, and P-
values corrected for multiple comparisons using Bonferroni correction) is shown. R1 DNA library normalized to NNK template (top left, 
~9 million sequences), R1 virus normalized to R1 DNA libraries (bottom left, ~10 million sequences), R2 GFAP library with enrichment 
score above 1.0 in brain normalized to R2 virus (top right, 20 sequences,) and R2 SNAP library with enrichment score above 1.2 
normalized to R2 virus (bottom right, 17 sequences) are shown (n = 1 for DNA, virus, and n = 2 for brain libraries). d, Clustering 
analysis of positively enriched variants from Tek, GFAP, and combined neuron brain libraries (SNAP and Syn) by PCR pool design, and 
by synthetic pool design with spike-in library are shown with size of nodes representing their relative enrichment in brain, and the 
thickness of edges (connecting lines) representing the extent of shared AA identity between nodes. A distinct family is highlighted in 
yellow with the corresponding AA frequency logo below (AA size reflects prevalence and color coded based on AA properties). 
 Supplementary Figure 4 
AAV-PHP.V1 Efficiently Targets the Brain Vasculature. 
a, Expression of AAV9 (above) and AAV-PHP.V1 (below) packaging ssAAV:CAG-mNeonGreen across all organs is shown (n=3, 
3x1011 vg dose per adult C57BL/6J mouse, 3 weeks of expression). The background auto fluorescence is represented in magenta. b, 
Expression in cortical astrocytes (S100+) after IV delivery of AAV-PHP.V1 (left) and AAV-PHP.eB (right) capsids carrying 
ssAAV:GfABC1D-2xNLS-mTurquoise2 (1x1012 vg dose per adult mouse, 4 weeks of expression). Percentage of cortical S100+ cells 
that overlapped with mTurquoise2 expression is quantified (n = 2, each data point is mean from 3 images per mouse). c, Expression of 
AAV9, AAV-PHP.eB (d), AAV-PHP.V1 (e) packaging ssAAV:Ple261-iCre in Ai14-tdTomato reporter adult mouse (n=2-3 per group, 
3x1011 vg dose per adult mouse, 3 weeks of expression). f, Expression of AAV-PHP.V1 carrying self-complementary (sc) scAAV:CB6-
EGFP (above) and scAAV:CAG-EGFP (below). Magenta represents the lectin DyLight 594 staining (n=2-3, 3x1011 vg dose per adult 
C57BL/6J mouse, 2 weeks of expression). Experiments in c-e are reported from one independent trial from a fresh batch of viruses, 
and tittered in the same assay for dosage consistency, e and f validated in two independent trials (n = 2 per group). 
 Supplementary Figure 5 
AAV-PHP.V2 Variant Exhibits Biased Transduction Towards Brain Vascular Cells. 
a, Transduction of mouse brain by the AAV-PHP.V2 variant and control AAV9, carrying the ssAAV:CAG-mNeonGreen (n = 3, 3x1011 vg 
IV dose per C57BL/6J adult mouse, 3 weeks of expression) is shown. The sagittal brain images (left) are matched in fluorescence 
intensity to the sagittal brain images in Fig. 3c. Higher magnification images of AAV-PHP.V2 transduced brain sections stained with 
αGLUT or αS100 or αOlig2 (magenta) are shown. b, Transduction of brain vasculature by AAV-PHP.V2 carrying ssAAV:CAG-DIO-
EYFP (green) in Tek-Cre adult mice (left, 1x1012 vg IV dose per mouse, 4 weeks of expression) is shown, and its efficiency (right) is 
determined by the overlap of αGLUT1 staining (red) with EYFP expression across different brain areas (n = 2, mean of 3 images per 
brain region per mouse) c, Transduction of astrocytes by AAV-PHP.V2 in GFAP-Cre adult mouse (1x1012 vg IV dose per mouse, 4 
weeks of expression) is shown. Percentage of cortical S100+ cells that overlapped with EYFP expression is quantified (n = 2, mean of 3 
images per mouse). 
 Supplementary Figure 6 
Further Validation of Synthetic Pool and PCR Pool Variants Demonstrates Higher Confidence in Synthetic Pool NGS Data. 
a, Transduction levels of liver hepatocytes quantified as the percentage of DAPI+ cells that are EGFP+ (n = 3, vectors packaged with 
ssAAV:CAG-2xNLS-EGFP, 1x1011 vg IV dose/adult C57BL/6J mouse, 3 weeks of expression, mean±S.E.M, 4 images per mouse per 
group. One-way ANOVA, non-parametric Kruskal-Wallis test gave an approximate P-value of 0.0088).  b, Transduction of brain tissue 
by AAV-PHP.B4, B7, AAV-PHP.X1 (ARQMDLS), and AAV-PHP.X2 (TNKVGNI) packaging ssAAV:CAG-mNeonGreen genome (n = 3, 
1x1011 vg IV dose/adult C57BL/6J mouse, 3 weeks of expression), matched in fluorescence intensity to AAV9 and AAV-PHP.V1 sagittal 
brain images in Fig. 3c. c, Transduction of the brain by AAV-PHP.B8 using the ssAAV:CAG-mRuby2 genome (n = 3, 3x1011 vg IV 
dose/adult C57BL/6J mouse, 3 weeks of expression). d, Transduction of AAV9 (left), AAV-PHP.X3 (QNVTKGV) (middle) and AAV-
PHP.X4 (LNAIKNI) (right) vectors packaging ssAAV:CAG-2xNLS-EGFP (n = 2, 1x1011 vg IV dose/adult C57BL/6J mouse, 3 weeks of 
expression). a-d data is reported from one independent trial. 
 Supplementary Figure 7 
Evolution of the AAV-PHP.B Capsid by Diversifying Amino Acid Positions 587-597. 
a, Distributions of R1 and b, R2 brain libraries (at AA level, standard score (SS) of RCs sorted in decreasing order of scores) is shown. 
The SS for AAV-PHP.N and AAV-PHP.eB across libraries are mapped on the zoomed-in view of this plot (dotted line box). c, Heatmap 
of AA distributions across the diversified region of the enriched variants from R2 liver library (top 100 sequences) normalized to the R2 
virus (input library). d, Clustering analysis of enriched variants from GFAP and Vglut2 brain libraries are shown with size of nodes 
representing their relative depletion in liver, and the thickness of edges (connecting lines) representing their relative identity between 
nodes. e, Expression of AAV-PHP.B (above) and AAV-PHP.N (below) packaged with ssAAV:CAG-mNeonGreen across all organs is 
shown (n = 3, 3x1011 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression). The background auto fluorescence is in magenta. 
f, Transduction of mouse brain by the AAV-PHP.N variant, carrying the CAG promoter that drives the expression of mNeonGreen (n = 
3, 1x1011 vg IV dose per C57BL/6J adult mouse, 3 weeks of expression) is shown. Fluorescence in situ hybridization chain reaction 
(FITC-HCR) was used to label excitatory neurons with Vglut1 and inhibitory neurons with Gad1. Few cells where EGFP expression co-
localized with specific cell markers are highlighted by asterisks symbol. 
 Supplementary Figure 8 
Investigation of AAV-PHP Variants Across Different Mouse Strains and In Vitro Human Brain Microvascular Endothelial Cells. 
a, Transduction of AAV9, AAV-PHP.eB and AAV-PHP.V1 in human brain microvascular endothelial cell culture (HBMEC) is shown. The 
vectors were packaged with ssAAV:CAG-mNeongreen. The mean fluorescence intensity across the groups were quantified (n=3 tissue 
culture wells of 0.95 cm2 surface area per group, 3 images per well per group per dose was imaged after three days of expression, 
doses 1x108 vg and 1x1010 vg per 0.95 cm2 surface area). A two-way ANOVA with correction for multiple comparisons using Tukey’s 
test gave adjusted P-value of 0.0051 for AAV9 vs PHP.V1, 0.0096 for PHP.eB vs PHP.V1, 0.8222 for AAV9 vs PHP.eB for 1x108 vg, 
and 0.0052 for AAV9 vs PHP.V1, 0.0049 for PHP.eB vs PHP.V1, 0.9996 for AAV9 vs PHP.eB for 1x1010 vg (**P ≤ 0.01, is shown and P 
> 0.05 is not shown on the plot; mean ± S.E.M., 95% CI). b, The transduction of cortex brain region by AAV-PHP.B, AAV-PHP.C2 and 
AAV-PHP.C3 across two different mouse strains: C57BL/6J and BALB/cJ are shown. The vectors were packaged with ssAAV:CAG-
mNeongreen (n = 2-3 per group, 1x1011 vg IV dose/ adult mouse, 3 weeks of expression). The fluorescence intensity is matched across 
all the images. The data reported in a,b are from one independent trial where all viruses were freshly prepared and tittered in the same 
assay for dosage consistency, with additional validation for AAV-PHP.C2 and AAV-PHP.C3 in an independent trial for BALB/cJ. 
 
 
 
SUPPLEMENTARY TABLES 1-4: 
 
 
 
Supplementary Table 1: Comparison between the two methods for R2 selection. 
The table summarizes the pros and cons of selection design parameters by the synthetic pool 
and PCR pool R2 selection methods. 
 
 
 
 
AAV 
Variants 
Synthetic pool 
enrichment rank 
PCR pool 
enrichment rank 
PCR pool           
read count rank 
PHP.V1 1 4 3 
PHP.V2 2 1 1 
PHP.B4 4 10 56 
PHP.B7 6 13 36 
PHP.B8 3 7 23 
PHP.C1 13 34 74 
PHP.C2 12 20 293 
PHP.C3 16 Not recovered Not recovered 
 
Supplementary Table 2: Ranking of AAV-PHP capsids across methods. 
Ranks of selected variants among all capsids recovered from R2 Tek-Cre selection by synthetic 
pool enrichment score (representing M-CREATE), PCR pool enrichment score (representing 
closer to M-CREATE), or PCR pool read counts (representing CREATE), the highest ranks of 
which starts from 1, and “Not recovered” represent absence of the variant from R2 sequencing 
data.    
 
 
 
 
 
 
 
 
 
 
Design Parameters Synthetic pool design PCR pool design 
Carryover of R1 selection bias among 
variants 
No, likelihood of false positives is low 
Yes, potential to minimize by 
normalization 
Carryover of R1 selection induced 
mutants 
No Yes 
Confidence in library performance High, using alternate codon replicates Low 
Customize library or add internal 
controls 
Yes, in an unbiased manner Yes, with greater risk of bias 
Control library size Yes, without reducing libraries or pooling Yes, with libraries reduced for pooling 
Cost for R2 library generation High Low 
 
 
 
AAV Variants Reference / Selection 
method 
Tropism Production Rounds of evolution 
from parent capsid 
PHP.B, B2, B3 Deverman et al, 2016 / 
CREATE 
Broad CNS 
transduction 
Good 1 round from AAV9 
PHP.A Deverman et al, 2016 / 
CREATE 
Astrocyte transduction Poor; prone to 
precipitate upon 
storage at 4oC. 
1 round from AAV9 
PHP.eB Chan et al, 2017 / CREATE Enhanced Broad CNS 
transduction 
Good 2 rounds from AAV9 or  
1 round from PHP.B 
PHP.S Chan et al, 2017 / CREATE Sensory neuron 
transduction 
Good 1 round from AAV9 
PHP.V1, V2 Current study / M-CREATE BBB Vascular cells and 
astrocytes transduction 
Good 1 round from AAV9 
PHP.B4, B7, B8,  Current study / M-CREATE Broad CNS 
transduction 
Good 1 round from AAV9 
PHP.B5, B6 Current study / M-CREATE 
and CREATE 
Broad CNS 
transduction 
Good 2 rounds from AAV9 or 
1 round from PHP.B 
PHP.C1, C2, C3 Current study / M-CREATE Broad CNS transduction 
across mouse strains 
Good; PHP.C1 prone 
to precipitate upon 
storage at 4oC. 
1 round from AAV9 
PHP.N Current study / M-CREATE 
and CREATE 
Neuron transduction Average 2 rounds from AAV9 or 
1 round from PHP.B 
*PHP variants – named in memory of late Professor Paul H. Patterson, Caltech. 
 
Supplementary Table 3: AAV-PHP vectors identified by CREATE and M-CREATE. 
The table provides a summary of the variants that have been identified so far using CREATE 
and M-CREATE, along with their tropism and the evolutionary steps from the parent capsid that 
was involved in their discovery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 4: Primers used in M-CREATE selection. 
The table provides a list of primers used in M-CREATE across the different steps of the 
selection process as described in the Methods. 
 
 
 
 
 
 
 
 
 
 
 
Primer name Sequence (5’-3’) Forward or 
reverse direction  
XF ACTCATCGACCAATACTTGTACTATCTCTCTAGAAC Forward 
7xMNN-588i GTATTCCTTGGTTTTGAACCCAACCGGTCTGCGCCTGTGCMNNMNNMNNMNNMNNMNNM
NNTTGGGCACTCTGGTGGTTTGTG 
Reverse 
588-R2lib-F  CACTCATCGACCAATACTTGTACTATCTCTCT Forward 
588-R2lib-R GTATTCCTTGGTTTTGAACCCAACCG Reverse 
11-mer-588i GTATTCCTTGGTTTTGAACCCAACCGGTCTGCGCXXXXXXMNNMNNMNNMNNMNNMNNMN
NXXXXXXACTCTGGTGGTTTGTG 
Reverse 
71F  CTTCCAGTTCAGCTACGAGTTTGAGAAC  Forward 
CDF/R  CAAGTAAAACCTCTACAAATGTGGTAAAATCG  Forward/Reverse, 
see Methods 
588i-lib-PCR1-6bpUID-F  CACGACGCTCTTCCGATCTAANNNNNNAGTCCTATGGACAAGTGGCCACA  Forward 
588i-lib-PCR1-R GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTCCTTGGTTTTGAACCCAACCG  Reverse 
1527  ACACTCTTTCCCTACACGACGCTCTTCCGATCTGACAAGTGGCCACAAACCACCAG  Forward 
1532 GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCCTTGGTTTTGAACCCAACCG  Reverse 
mNeonGreen-F  CGACACATGAGTTACACATCTTTGGCTC  Forward 
mNeonGreen-R  GGAGGTCACCCTTGGTGGACTTC  Reverse 
Mito-F  CCCAGCTACTACCATCATTCAAGT  Forward 
Mito-R  GATGGTTTGGGAGATTGGTTGATGT  Reverse 
CapF-56 ATTGGCACCAGATACCTG ACTCGTAA Forward 
Cre-R-57 GTCCAAACTCATCAATGTATCTTATCATGTCTG Reverse 
NGS-QC-F AATGATACGGCGACCACCGAG Forward 
NGS-QC-R CAAGCAGAAGACGGCATACGA Reverse 
 
 
 
Supplementary Table 5: Sequence motifs of AAV-PHP variants  
The table provides the sequence motif information for all the new AAV-PHP variants identified in 
this study, and the primer information to clone them into pUCmini-iCAP-PHP.B backbone 
(Addgene ID: 103002) as described in Methods. The variants from 7-mer-i and 3-mer-s libraries 
were cloned as 11-mer substitution. 
 
 
Variant Name Amino acid motif of variants with 
“AQ” overhangs from AAV9: 
AA587-88 and AA589-90. (11-
mer) 
Nucleotide sequence 
of 11-mer 
Forward primer (5’-3’) Reverse primer (5’-3’) 
AAV-PHP.V1 
(Addgene ID: 
127847) 
AQTALKPFLAQ GCCCAAACCGCCCT
CAAACCCTTCCTCG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAACCGCCCTCAA
ACCC 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCGA
GGAAGGGTTTGAGGGCGGT
TTGGGC 
AAV-PHP.V2 
(Addgene ID: 
127848) 
AQTTLKPFLAQ GCCCAAACCACCCT
CAAACCCTTCCTCG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAACCACCCTCAAA
CCC 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCGA
GGAAGGGTTTGAGGGTGGT
TTGGGC 
AAV-PHP.B4 
(Addgene ID: 
127849) 
AQTLQIPFKAQ GCCCAAACGTTGCA
GATTCCTTTTAAGG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAACGTTGCAGATT
CCT 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCCTT
AAAAGGAATCTGCAACGTTT
GGGC 
AAV-PHP.B5 AQTLQLPFKAQ GCCCAAACCCTCCA
ACTCCCCTTCAAAG
CCCAA 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAACCCTCCAACTC
CCC 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCTTGGGCTTT
GAAGGGGAGTTGGAGGGTT
TGGGC 
AAV-PHP.B6 AQTLQQPFKAQ GCCCAAACTTTGCA
GCAGCCGTTTAAGG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAACTTTGCAGCAG
CCG 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCCTT
AAACGGCTGCTGCAAAGTTT
GGGC 
AAV-PHP.B7 AQSIERPFKAQ GCCCAAAGCATCGA
AAGACCCTTCAAAG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAAGCATCGAAAG
ACCC 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCTTT
GAAGGGTCTTTCGATGCTTT
GGGC 
AAV-PHP.B8 AQTMQKPFIAQ GCCCAAACCATGCA
AAAACCCTTCATCG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAACCATGCAAAAA
CCC 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCGA
TGAAGGGTTTTTGCATGGTT
TGGGC 
AAV-PHP.C1 AQRYQGDSVAQ GCCCAAAGGTATCA
GGGTGATTCTGTTG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAAGGTATCAGGG
TGAT 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCAA
CAGAATCACCCTGATACCTT
TGGGC 
AAV-PHP.C2 AQWSTNAGYAQ GCCCAATGGTCGAC
AAACGCTGGTTACG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAATGGTCGACAAA
CGCT 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCGT
AACCAGCGTTTGTCGACCAT
TGGGC 
AAV-PHP.C3 AQERVGFAQAQ GCCCAAGAGCGTGT
AGGTTTCGCACAGG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAGAGCGTGTAGG
TTTC 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCCT
GTGCGAAACCTACACGCTCT
TGGGC 
AAV-PHP.N 
(Addgene ID: 
127851) 
AQTLAVPFSNP GCGCAGACCCTAG
CTGTCCCTTTTTCG
AACCCT 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCGCAGACCCTAGCTGT
CCCT 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCAGGGTTCG
AAAAAGGGACAGCTAGGGTC
TGCGC 
AAV-PHP.X1 AQARQMDLSAQ GCCCAAGCCAGACA
AATGGACCTCAGCG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAGCCAGACAAAT
GGAC 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCGC
TGAGGTCCATTTGTCTGGCT
TGGGC 
AAV-PHP.X2 AQTNKVGNIAQ GCCCAAACCAACAA
AGTCGGCAACATCG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAAACCAACAAAGTC
GGC 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCGA
TGTTGCCGACTTTGTTGGTT
TGGGC 
AAV-PHP.X3 AQQNVTKGVAQ 
 
GCCCAACAGAACGT
AACGAAGGGTGTG
GCACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAACAGAACGTAAC
GAAG 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCCA
CACCCTTCGTTACGTTCTGT
TGGGC 
AAV-PHP.X4 AQLNAIKNIAQ 
 
GCCCAACTCAACGC
TATCAAGAACATCG
CACAG 
GGAGTCCTATGGACAAGT
GGCCACAAACCACCAGAG
TGCCCAACTCAACGCTATC
AAG 
TTCCTTGGTTTTGAACCCAA
CCGGTCTGCGCCTGTGCGA
TGTTCTTGATAGCGTTGAGT
TGGGC 
 
 
SUPPLEMENTARY NOTES 1-29: 
 
Supplementary Note 1: Spike-in and PCR pool library 
AAV9 and ~50 additional variants (and their alternative codon duplicates), identified in 
previously described work1,2 (includes well characterized variants like AAV-PHP.B or AAV-
PHP.eB as well as many variants identified using the previous methodology but uncharacterized 
in vivo) act as internal selection controls and standards for the relative performance of the new 
variants (see Supplementary Dataset 1). The PCR pool library was generated by pooling the 
amplicons from the R1 brain selections after normalization based on their relative diversity (see 
Methods). 
 
Supplementary Note 2: Experimental noise 
The degree of enrichment at which correlation breaks down appears to vary with Cre-line. A 
downside of PCR pool is that there is no way to tell whether it or synthetic pool is the more ‘true’ 
enrichment score, or even that there may be cause for concern regarding certain enrichment 
values. The correlation among positively enriched variants between the two methods were 
found to improve with the magnitude of positive enrichment. For each experiment there is a 
level of enrichment below which the scores become irreproducible, or noisy.  
Supplementary Fig. 3a demonstrates that neither PCR pool nor Synthetic pool is inherently 
more ‘true’ at lower enrichment scores. This is because Synthetic pool methodology with its 
codon replicates has a self-contained control to determine an enrichment level below which 
enrichment value has no further predictive power. In the main text we use the term ‘noise’ to 
refer to regions of enrichment in a particular experiment below which values lose their 
reproducibility and predictive power. Being able to experimentally determine enrichment signal 
above noise allows researchers to focus their attention and data analyses on enrichment levels 
that are internally reproducible and thereby avoid selecting false positive variants or drawing 
invalid conclusions.  
Thus, if one is interested in only the highest enriched variants for a particular tissue, PCR pool 
design coupled with enrichment normalization to virus library may not drastically differ from 
synthetic pool design over one additional round of selection for a subset of in vivo selections 
(such as Tek-Cre or SNAP-Cre). Without additional validation, however, it is difficult to predict 
whether a given in vivo system will perform akin to Tek-Cre. This becomes critical in a 
multiplexed selection study where target-specific variants may not garner the highest 
enrichments in one particular in vivo selection.  
 
Supplementary Note 3: The dominance of PHP.B-like motif 
The ability to twice recover the AAV-PHP.B sequence family from completely independently 
constructed and selected libraries confirms that the viral library’s sequence space coverage was 
broad enough to recover a family of variants sharing a common motif. Unlike CREATE which 
identified only one variant, AAV-PHP.B, M-CREATE yielded a diverse PHP.B-like family that 
hints toward important chemical features of this motif. The sequence diversity within this family 
 
 
suggests that isolating AAV-PHP.B was not simply good fortune in our prior study (considering a 
theoretical starting library size of ~1.3 billion), and that this is a dominant family for this 
particular experiment. 
 
Supplementary Note 4: AAV-PHP.V2 capsid 
AAV-PHP.V2 was found at high abundance in R1 selection across all brain libraries and was 
highly enriched in R2 (Fig. 1d, 2g (right panel), 3a,b, Supplementary Fig. 1e). Given its 
sequence similarity, we predicted similar tropism to that of AAV-PHP.V1. We validated this in 
vivo in C57BL/6J adult mice (ssAAV-PHP.V2:CAG-mNeongreen genome, 3x1011 vg dose per 
adult mice, n = 3, Supplementary Fig. 5a), in Tek-Cre mice (ssAAV-PHP.V2:CAG-DIO-EYFP 
genome, 1 × 1012 vg dose per adult mouse, n = 2, Supplementary Fig. 5b), and in GFAP-Cre 
mice (ssAAV-PHP.V2:CAG-DIO-EYFP, 1 × 1012 vg dose per adult mouse, n = 2, Supplementary 
Fig. 5c). 
 
Supplementary Note 5: Spike-in library validation in vivo 
To evaluate the performance of the spike-in library, we chose two highly enriched variants 
similarly placed in sequence space: AAV-PHP.B6 – TLQLPFK and AAV-PHP.B7 – TLQQPFK 
(Supplementary Fig. 2d (middle panel), 3d) that were previously identified in the 3-mer-s PHP.B 
library2 but never validated in vivo. At a modest dose of 1x1011 vg in C57BL/6J adult mice, these 
variants also display PHP.B-like tropism (Fig. 4a,b, Supplementary Fig. 6a). 
 
Supplementary Note 6: 3-mer-s PHP.B library design 
Briefly, the re-investigated 3-mer-s PHP.B library diversified positions 587-597 of the AAV-
PHP.B capsid (equivalent of 587-590 AA on AAV9) in portions of three consecutive AAs, 
(~40,000 total variants) (Fig. 5a). Selections were performed in three Cre-transgenic lines: 
Vglut2-IRES-Cre for glutamatergic neurons, Vgat-IRES-Cre for GABAergic neurons, and GFAP-
Cre for astrocytes. 
 
Supplementary Note 7: Lack of neuronal subtype-specific selection 
While Vglut2-Cre and Vgat-Cre mice were used for in vivo selection, we didn’t find variants that 
stood out for neuronal subtype-specific transduction of excitatory and inhibitory populations from 
our initial investigations on the NGS dataset. It is possible that a biological solution to this 
(stringent) selection was not present in this library. 
 
Supplementary Note 8: Plasmids for library generation 
The rAAV-Cap-in-cis-Lox2 plasmid consists of three major elements that are flanked by AAV2 
ITRs. 
 
 
(i) UBC ubiquitous promoter driving the expression of fluorescent protein, mNeongreen, 
followed by a synthetic polyadenylation sequence. The mCherry expression cassette of the 
previous version of the plasmid was replaced by mNeonGreen cassette.  
(ii) A portion of AAV2 rep gene that has the splicing sequences and AAV5 p41 promoter (1680-
1974 residues of GenBank AF085716.1) followed by AAV9 cap gene. The prior version of this 
plasmid, rAAV-ΔCap-in-cis-Lox, has a short 12 bp sequence between restriction sites XbaI and 
AgeI at AA 450 and 592 of the AAV9 Cap gene. This was replaced by a 723 bp sequence of 
mRuby2 gene in-frame (acts as filler DNA) in the newer version of the plasmid.  
(iii) SV40 polyadenylation sequence that is flanked by lox71 and lox66 sites. The minor changes 
were introduced to the prior version of the plasmid to facilitate ease of cloning and to visualize 
mammalian cell transfection. The Lox sites in these rAAV plasmids show modest levels of Cre-
independent flipping. This was minimized during PCR-based capsid recovery by lowering the 
number of amplification cycles to a point where we cannot recover any rAAV capsids from the 
control DNA extracted from wild-type mice (i.e., lacking Cre expression) that were injected with 
the library. 
The pCRII-9Cap-XE plasmid contains the AAV9 capsid gene sequence from AAs 450-592 and 
is flanked by XbaI and AgeI restriction sites. 
The AAV2/9 REP-AAP-Cap plasmid has the five previously existing stop codons of AAV2/9 
REP-AAP in addition to the deletion of AAs 450-592 of the AAV9 capsid sequence. These 
modifications did not affect vector production. The deletion of the overlapping fragment between 
the REP-AAP and rAAV-Cap-in-cis-Lox2 plasmids minimizes recombination between plasmids 
that could potentially generate AAV9 wild-type capsids during co-transfection in vector 
production. 
 
Supplementary Note 9: Plasmids for capsid characterization 
pAAV:CAG-mNeonGreen2 genome consists of a ubiquitous CMV-β-Actin-intron-β-Globin (CAG) 
hybrid promoter driving the expression of a fluorescent protein, mNeonGreen (equivalent 
plasmid, pAAV: CAG-eYFP3; Addgene ID: 104055). pAAV:CAG-NLS-EGFP1 consists of NLS 
sequences at the N- and C-termini of EGFP and is driven by the CAG promoter. An equivalent 
version with one NLS is on Addgene (ID 104061). pAAV:CAG-DIO-EYFP3 (Addgene ID: 
104052) consists of a EYFP gene built in the reverse direction of the CAG promoter, and it is 
flanked by a pair of Cre-Lox sites (Lox P and Lox 2272) on either ends. In cells expressing Cre, 
the Cre-lox pair inverts EYFP enabling transcription and translation, followed by excision in the 
lox site to prevent re-inversion. pAAV: GfABC1D-2xNLS-mTurquoise23, referred to elsewhere 
as pAAV:GFAP-2xNLS-mTurquoise2 ( Addgene ID: 104053), consists of NLS sequences at the 
N- and C-termini of mTurquoise2 and is driven by the astrocyte-specific promoter GfABC1D4. 
pAAV:Ple261-iCre5 (Addgene ID 49113) contains an endothelial-cell-specific promoter driving 
the expression of iCre.  
We packaged pAAV:CAG-XFP (mNeongreen) for characterizing AAV variants. However, when 
performing quantification of cell-types: neurons, astrocytes and oligodendrocytes, we use CAG-
NLS-EGFP to restrict the expression to nucleus for easier quantification using microscope 
 
 
images. GFAP-NLS-mTurq2 is used to quantify astrocytes. CAG-DIO-EYFP is used for Cre 
driver lines, due to the presence of lox sites in this plasmid. 
The self-complementary genome from Dr. Guangping Gao, scAAV:CB6-EGFP genome has a 
hybrid ubiquitous CB6 promoter (975 bp) comprising a CMV enhancer (cytomegalovirus 
immediate early enhancer), a chicken-β-actin promoter and hybrid intron, that drives the 
expression of EGFP. The genome has a rabbit globin poly A (127 bp) following the EGFP gene. 
The scAAV:CAG-EGFP6 (Addgene ID:83279), vector uses a ubiquitous CMV-β-Actin-intron-β-
Globin (CAG) hybrid promoter to drive the expression of EGFP. 
 
Supplementary Note 10: AAV capsid library generation 
To avoid PCR-induced biases resulting from point mutations, recombination, and template 
switching, PCR amplification of the library was limited to 15 – 20 cycles and the reactions were 
scaled up to get the required yield. The resulting PCR products were run on a 1% agarose gel 
and extracted with a Zymoclean Gel DNA Recovery kit (Zymo Research; D4007). It is critical to 
avoid AAV contamination during this step by taking precautionary measures like using a clean 
gel-running box and freshly prepared 1× TAE buffer. 
 
Supplementary Note 11: Quality control for AAV capsid library generation 
The following four steps were carried out to ensure successful capsid library generation. 
1. To validate successful assembly of the library, 1 ng of the final assembled library was 
transformed into E. coli SURE 2 Supercompetent Cells (Integrated Sciences; 200152). We 
checked for colonies on an LB/Agar plate containing carbenicillin antibiotic after overnight 
incubation at 37°C.  
2. The DNA library was sequenced around the insertion site (Laragen; Sanger Sequencing). A 
non-biased library may match the diversity of the NNK/MNN motif (where N = 25% each of A, T, 
G, C; K = 50% each of G, T; M = 50% each of A, C) with some fluctuations across the 
diversified region.  
3. To verify that the ITRs were intact, SmaI digestion was carried out as per the NEB 
recommended protocol (NEB; R0141S).  
4. To validate successful transfection and assess the vector-production yield per 150 mm dish, 
10 ng of 7-mer-i library was used to transfect 293T producer cells (293T; ATCC CRL 3216). 
Uniform expression of mNeonGreen protein across HEK cells was observed, and an average 
yield of 0.1 – 1x1011 vg was obtained per 150 mm dish. Using the average yield per dish, we 
scaled up the vector production for in vivo selection (see Supplementary Fig. 2a). 
 
Supplementary Note 12: Estimation of high-confidence variants from round-1 selection 
This process involved estimation of the diversity precluding noise and consideration of 
amplification of this diversity across samples by determining the area under the curve for the 
interval of high-confidence variants that falls in the higher RC range. We estimated the area 
 
 
under the curve (AUC) using the composite Simpson’s rule by plotting all the recovered variants 
in a library (X-coordinate) to their read counts (RCs or copy number from deep sequencing data, 
Y-coordinate) (see Supplementary Fig. 1e). To determine the definite intervals for AUC, we 
sorted the data based on the decreasing order of the RCs. Noticeably, the distribution has two 
phases, with a steadier slope of variants in the higher RC range, followed by a steep drop in the 
slope of the curve (~50-1000 fold lower RCs). By observation, this steeper side of the curve is 
predominant in sequencing errors/ PCR mutations, hence we precluded this error dominant 
slope otherwise called noise from our AUC estimation. When comparing composite Simpson’s 
rule with another function, such as composite trapezoidal rule, the difference was miniscule.  
This area is then used to determine the fraction of an individual library that needs to be pooled 
into PCR pool library using the formula: [Area under the curve/ total number of libraries pooled]. 
 
Supplementary Note 13: R2 library generation and vector production 
The R1 libraries used to build R2 were the Cre-Lox flipped rAAV DNA from half of the mouse 
brains (~0.3 g) and portion of spinal cords (0.1-0.2g) from all Cre lines. The amount of tissue 
processed here was sufficient for complete capsid library recovery. The differentially pooled and 
amplified libraries (by PCR pool or synthetic pool) were assembled using gibson assembly with 
a follow-up PS or Exonuclease V treatment (as described in R1 library generation). We 
validated successful library generation by transformation, Sanger sequencing, and an ITR SmaI 
digest.  
For vector production, about 10 ng of the purified and assembled library was used to transfect 
each 150 mm dish of 293T cells, and we obtained a yield of about 6×1011 vg per 150 mm dish 
(i.e. the R2 yield was six times that of R1, unsurprisingly given these sequences have already 
produced well enough to survive R1 selection). 
 
Supplementary Note 14: AAV virus library production 
In addition to the 10 ng of library transfection per 150 mm dish of 293T producer cells, we 
transfected three plasmids: AAV2/9 REP-AAP-Cap, pUC18 and pHelper (genes encoding 
adenoviral proteins for AAV replication) at a ratio of 1:1:2. The plasmid pUC18 acts as a filler 
DNA to compensate for the low amount of library DNA in order to maintain the N:P ratio 
required for optimal transfection using polyethylenimine (PEI, Polysciences; 24765-1) 
transfection). The cells and culture media were harvested at 60 h post-transfection to collect the 
viral particles. rAAV harvest and purification were performed as per the protocol3. The small 
amount of library DNA per plate and early cell harvest time are critical for reducing the 
possibility of mosaic capsid assemblies during vector production (similar considerations seen in 
prior reports7–9). 
For 7-mer-i library, the production was scaled up to 60 dishes (~1.8x107 cells/dish) and with 
~10% transfected with the library, resulted in ~1x108 total transformants. For an NNK 7mer 
library with ~1x108 total transformants, the number of unique variants is 9.99x107 (See Bosley & 
Ostermeier (2004)10, section 2.1.2 for mathematics). 
 
 
 
Supplementary Note 15: rAAV genome extraction by proteinase K 
In order to degrade any contaminating DNA from the purified library, it was treated with DNase I 
enzyme (5 µl of 10 U/µl) (Sigma-Aldrich; 4716728001) in 100 µl of DNase I buffer and incubated 
for 1 h at 37°C. The enzyme was inactivated by adding 5 µl of 0.5 M EDTA at 70°C for 10 min. 
Following DNase I treatment, the capsid protein shell was digested by adding 120 µl of 
proteinase solution containing 5 µl of 20 µg/µl of proteinase K and incubated at 50°C overnight. 
To inactivate the proteinase K, the mixture was boiled at 95°C. The extracted rAAV library DNA 
was then concentrated and purified using phenol chloroform and ethanol. An equal volume of 
Phenol:Chloroform:Isoamyl Alcohol 25:24:1, pH8.0 (~250 µl; ThermoFisher Scientific; 
15593031) was added and vortexed for 30 s. The mixture is incubated for 5 min at room 
temperature (RT) before centrifugation at 15,000 rpm for 10 min at 4°C. The upper aqueous 
phase was separated and mixed with an equal volume of chloroform and vortexed for 30 s. 
Following 5 min incubation at RT, centrifuge at 15,000 rpm for 10 min at 4°C. The upper 
aqueous phase was separated and one-tenth volume of 3M sodium acetate (pH 5.2) along with 
2 µl Co-Precipitant Pink (Bioline; BIO-37075) and 2.5 volumes of ice cold 100% ethanol was 
added before vortexing for 30 s. The mixture was incubated for at least 1 hr at -20°C before 
centrifugation at 15,000 rpm for 15 min at 4°C. The pellet was air dried and resuspended in TE 
buffer. The DNA concentration was determined using the Qubit ssDNA assay. 
 
Supplementary Note 16: Optimization of rAAV genome extraction from tissue 
For rAAV genome extraction from tissues, we used both the Trizol method (Life Technologies; 
15596) and the QIAprep Spin Miniprep kit (Qiagen, Inc; 27104) according to the manufacturers’ 
recommended protocols, and found the Trizol method to be more efficient (see Supplementary 
Fig. 1f,g,i). The total rAAV genome recovery from 0.1 g of mouse liver was quantified by 
quantitative PCR using the primers mNeonGreen-F and mNeonGreen-R, which binds to the 
mNeonGreen gene of the ssAAV-Cap-in-cis-Lox2 genome (see Supplementary Table 4). As 
an internal control, we also quantified the amount of mitochondrial DNA (a surrogate for the 
recovery of circular, episomal genomes) using primers Mito-F and Mito-R (see Supplementary 
Table 4). Although the percentage of viral DNA per 1 ng total extracted DNA was about 1.5 fold 
higher with the QIAprep kit than with the Trizol method, the overall recovery was lower with the 
QIAprep kit. 
The extracted viral genome was digested with a restriction enzyme, such as SmaI (found within 
the ITRs), as it appeared to help improve rAAV genome recovery by PCR with ~4 fold change 
(see Supplementary Fig. 1h, ΔCT ~ 2, 1 CT = 2-fold difference in DNA copies, fold change = 
(2ΔCT) = 4). This was analyzed by quantitative PCR with Cre− primers, CapF-56 and Cre-R-57 
(see Supplementary Table 4). 
 
Supplementary Note 17: The optional UID feature 
The primer, 588i-lib-PCR1-6bpUID-F: 5’ 
CACGACGCTCTTCCGATCTAANNNNNNAGTCCTATGGACAAGTGGCCACA-3’ used to 
minimally amplify DNA and virus libraries for NGS has 6 nucleotides long UID (unique identifier) 
“NNNNNN” that sits after 19 nucleotides of Read-1 sequence used in NGS “5’-
 
 
CACGACGCTCTTCCGATCT” and linker “AA”. The sequence after UID 
“AGTCCTATGGACAAGTGGCCACA” is the region that anneals to the AAV9 capsid. UID is an 
optional feature for NGS data analysis to identify potential PCR amplification errors. However, 
this feature wasn’t utilized in the NGS data analysis in this study to maintain consistency with 
the primers used in rAAV genome recovery from tissues which lacks this UID feature (primers 
71F and CDF/R, See Supplementary Table 4). The UID or any kind of overhangs seemed to 
affect the PCR based recovery from tissue. Presumably, the primer thermostability have a key 
role to play in very low amount of extracted rAAV genomes from tissues. 
 
Supplementary Note 18: Additional processing and consideration for NGS sample 
preparation 
The PCR products post indices addition were run on a freshly prepared 2% low-melting-point 
agarose gel (ThermoFisher Scientific; 16520050) for better separation and recovery of the 
approx. 120 bp DNA band on the gel. Before sending the sample for NGS, the nucleotide 
diversity at the randomized 7-mer position was verified by Sanger sequencing. If needed, an 
optional PCR was carried out to send sufficient sample for Sanger sequencing using 15 – 20 
cycles of 98°C for 10 s, 60°C for 30 s, and 72°C for 10 s with the primers NGS-QC-F and NGS-
QC-R (see Supplementary Table 4). Upon validation, the libraries were sent for deep 
sequencing using the Illumina HiSeq 2500 System (Millard and Muriel Jacobs Genetics and 
Genomics Laboratory, Caltech; Integrative Genomics Core, City of Hope). 
 
Supplementary Note 19: AAV dosage and expression time 
The AAV doses are determined by the experimental needs. CAG-NLS-GFP related experiments 
for quantification were done at medium dose of 1x1011 vg given this was the dose previously 
determined for AAV-PHP.eB characterization. Otherwise, the non-NLS genome related 
experiments were done at 3x1011 vg, with the exception of Cre-driver lines (GFAP-Cre or Tek-
Cre), or a lower strength promoter containing genome (GFAP-NLS-mTurq) where the dose was 
1x1012 vg. The high dose was chosen to understand the full potential of the new vectors in these 
systems. 
All experiments with vectors carrying CAG, a strong ubiquitous promoter, were incubated for 3 
weeks. The 4 week incubations are those that involved expression from Cre driver lines or cell-
type specific promoter where it is generally recommended for a longer wait time. The 2 week 
incubations are those where the vectors carried self-complementary genomes with strong 
ubiquitous promoters. 
 
Supplementary Note 20: Immunohistochemistry 
Tissue sections, typically 100-µm thick, were first incubated in blocking buffer (10% normal 
donkey serum, 0.1% Triton X-100, and 0.01% sodium azide in 0.1 M PBS, pH 7.4) with primary 
antibodies at appropriate dilutions for 24 h at RT on a rocker. The primary antibodies used in 
this study were rabbit S100 (1:400, Abcam, ab868), rabbit Olig2 (1:400; Abcam, ab109186), 
rabbit NeuN (1:400, Abcam, ab177487), and rabbit GLUT-1 (1:400; Millipore Sigma, 07-1401). 
 
 
After primary antibody incubation, the tissues were washed 1 – 3 times with wash buffer 1 (0.1% 
Triton X-100 in 0.1 M PBS buffer, pH 7.4) over a period of 5 – 6 h in total. The tissues were then 
incubated in blocking buffer with the secondary antibodies at appropriate dilutions for 12 – 24 h 
at RT and then washed in three times in 0.1 M PBS, pH 7.4 over a total duration of 5 – 6 h. The 
secondary antibody was Alexa Fluor 647 AffiniPure donkey anti-rabbit IgG (H+L) (Jackson 
ImmunoResearch Lab, 711-605-152). When performing DNA staining, 4′,6-Diamidine-2′-
phenylindole dihydrochloride (DAPI, Sigma Aldrich, 10236276001) is used at a 1:1000 dilution 
in 0.1 M PBS, pH 7.4 and incubated with tissues for 15 minutes followed by a single wash for 10 
minutes in 0.1 M PBS, pH 7.4. The DAPI and/or antibody-stained tissue sections were mounted 
with ProLong Diamond Antifade Mountant (ThermoFisher Scientific, P36970). 
 
Supplementary Note 21: Tissue processing for hybridization chain reaction 
To characterize the AAV capsid variant AAV-PHP.N in brain tissue, HCR method was sought to 
label excitatory and inhibitory neurons. Fluorescence in situ hybridization chain reaction (FITC-
HCR) was used to label excitatory neurons with VGLUT1 and inhibitory neurons with GAD1. 
Adapting the third-generation HCR11, we designed 13 probe sets for each target by using 
custom-made software (https://github.com/GradinaruLab/HCRprobe). After 3 weeks of 
expression, the mice were transcardially perfused and fixed as described earlier (Section D. 
Tissue processing). To minimize RNase enzyme exposure in fixed tissues, following overnight 
fixation in 4% PFA, the tissues were washed and stored at 4°C in 0.1 M RNase-free PBS and 
0.05% sodium azide. The harvested brains were henceforth handled with care to avoid 
exposure to RNase using reagents such as RNAlater stabilization solution/RNase-free PBS/ 
RNaseZap (ThermoFisher Scientific, AM7021, AM9624, AM9780). Once the harvested brains 
were sagittally sliced to 100-µm thick sections, we performed FITC-HCR to detect both genes. 
We permeabilized tissue slices with 0.1% Triton X-100 in 0.1 M RNase-free PBS for 1 h at RT 
and pre-hybridized them in hybridization solution (10% dextran sulfate and 10% ethylene 
carbonate in 2xSSC buffer (saline-sodium citrate)) for >30 min at 37oC. The designed probes 
were diluted in hybridization solution to get a final concentration of 2 nM. The tissue sections 
were then subjected to hybridization with the probes overnight at 37oC. Following this, the 
sections were washed with pre-warmed wash buffer (10% ethylene carbonate in 2xSSC) at 
37oC for 30 min twice, followed by 2xSSC at RT for 30 min twice. Amplification with hairpin pairs 
(Molecular Technologies, CA) were performed in amplification buffer (10x dextran sulfate in 
2xSSC); hairpins were snap-cooled at 95oC for 90 s, followed by RT for 30 min, and diluted with 
amplification buffer (60 nM). Tissues were then incubated in this amplification buffer with 
hairpins overnight at RT with gentle agitation. Once the amplification was done, samples were 
briefly washed with 2xSSC and mounted in Prolong Diamond for imaging. 
 
Supplementary Note 22: Measures to prevent imaging artifacts 
To prevent any imaging artifacts resulting from multiple fluorescence spectral overlap, the 
fluorescence excitation and emission spectra were kept distinct following the recommended 
linear unmixed acquisition of individual colors. A far-red fluorescent dye was chosen for any 
additional marker staining to keep the imaging parameters distinct from in vivo fluorescent 
expression thereby preventing any spectral overlap across detector channels. The tissues were 
routinely monitored for auto fluorescence or imaging artifacts before acquisition, and imaging 
 
 
parameters were adjusted if needed. The imaging parameters were cross-checked with tissues 
lacking in vivo transduction to avoid any imaging artifacts. The regions used for the images were 
closely matched across experimental groups to minimize bias during comparisons. 
 
Supplementary Note 23: Tissue clearing, optical clearing and imaging of thick tissues 
To demonstrate the ability of PHP.V1 to transduce the vasculature across thick tissues, such as 
a mouse-brain hemisphere, we assessed tissue from Tek-Cre mice 4 weeks’ post 
administration. The brain hemisphere was stained with the primary antibody, Anti-GFP (1:200, 
Aves Labs, GFP-1020), and the secondary antibody, goat anti-Chicken IgY, Alexa Fluor 633 
(1:200, ThermoFisher Scientific, A-21103), and cleared via the iDISCO protocol12. For imaging, 
a commercial light-sheet microscope (Lavision BioTec) with a custom objective lens (4×) was 
used13. The resulting image files were reorganized by a custom MATLAB script to allow stitching 
with TeraStitcher14. For 3-D visualization, Imaris (Bitplane) was used. 
For images of peripheral organs such as heart, muscle, spleen that were over 500 microns in 
thickness, optical clearing was performed by incubating the tissues in 5 ml of ScaleS4(0)15 
solution overnight at RT with gentle agitation, then mounted the tissues in fresh ScaleS4(0) 
solution and imaged under the confocal microscope.  
 
Supplementary Note 24: Tissue processing and imaging for quantification of rAAV 
transduction in vivo 
For quantification of PHP.B-family variant transduction in tissues, the images were acquired 
using 25x objective with 1x digital zoom on a Zeiss LSM 880 confocal microscope. With n=3 
mice per variant, images were acquired across 4 brain regions – cortex, striatum, ventral 
midbrain and thalamus and tissues were stained with 3 cell type markers (NeuN, Olig2, and 
S100). For each mouse, 2 images per brain region per cell type marker were acquired, and the 
mean were plotted. 
For PHP.N transduction analysis, the images were acquired using 20x objective on Keyence 
BZ-X700 microscope. With n=3 mice, images across 4 brain regions - cortex, striatum, ventral 
midbrain and thalamus were acquired to cover the entire brain regions for 3 cell type markers 
(NeuN, Olig2, and S100). This involved 6-8 images to cover cortex, thalamus and striatum, and 
2 images to cover ventral midbrain per mouse per cell-type marker. For each mouse, across 
each region, the mean from the images were plotted. 
For PHP.V GLUT1+ transduction analysis, the images were acquired using 25x objective with 1x 
digital zoom on a Zeiss LSM 880 confocal microscope. Each distinct blood vessel in the image 
with GLUT1+ staining and XFP expression was determined as positive for transduction. 
Quantification of expression from the CAG-mNeonGreen vector was performed across the 
cortex (n = 3 per group). Each data point is drawn from the mean of 3-2 images per mouse. 
Different brain regions were quantified for Tek-Cre and Ai14 mouse experiments with n = 2 per 
group. For cortex, cerebellum, striatum and ventral midbrain, the mean was plotted from 3-4 
images per mouse per region. 
 
 
 
Supplementary Note 25: Quantification of rAAV vector transduction  
Manual counting was performed for GLUT-1-stained blood vessels and expression of the 
ssAAV:CAG-mNeonGreen and ssAAV:CAG-DIO-EYFP, where the efficiency was calculated as 
the percentage of XFP+ vessels relative to the GLUT-1 staining. Manual counting was also 
performed to quantify nuclear or soma stained cells, including NeuN-, Olig2-, and S100-stained 
cells. The efficiency was calculated as the percentage of XFP+ cells relative to cell-marker+ 
cells.  
Keyence Hybrid Cell Count software (BZ-H3C) was used to quantify expression of nuclear 
localized AAV genomes in liver hepatocytes that co-localized with the DNA stain, DAPI; and 
also for the study involving ssAAV:GFAP-2xNLS-mTurquoise2 genomes with S100 cell marker. 
The mean fluorescence intensity across microscopic images were quantified using ImageJ 
software. The images were processed for background subtraction and using the Threshold 
operation, the mean fluorescence intensity was measured. 
 
Supplementary Note 26: NGS raw data processing  
The pipeline to process these datasets involved filtering the dataset to remove the low-quality 
reads by using the deep sequencing quality score for each sequence. The variant sequences 
were then recovered from the sequencing reads by searching for the flanking template 
sequences, and extracting the nucleotides of the diversified region (perfect string match 
algorithm). The quality of the aligned data was further investigated to remove any erroneous 
sequences (such as ones with stop codons). The raw data was plotted (as shown in 
Supplementary Fig. 1e) to study the quality of recovery across every library. Based on the RC 
distribution, we adapted a thresholding method to remove plausible erroneous mutants that may 
have resulted from PCR or NGS based errors. The assumption is that if there is a PCR mutation 
or NGS error on the recovered parent sequence, the parent must have existed at least one 
round earlier than the erroneous sequence, and thus a difference in RCs should exist.  
For R1 tissue libraries, we observed a steep drop in the slope of the distribution curve following 
a long tail of low count sequences, and were found to be rich in sequences that are variations of 
the parents in the higher counts range. We manually setup a threshold for RCs to remove such 
erroneous mutants. The thresholded data were then processed differently based on the 
experimental needs as described elsewhere using custom Python based scripts. 
For R2 tissue libraries from PCR pool and synthetic pool, given the smaller library size 
compared to R1, we thresholded the data in two steps. We only considered the tissue recovered 
sequences that were present in the respective input DNA and virus library (after removing lower 
count variants from input libraries following the same principle as R1 tissue libraries). This step 
partially removed the long tail of low count reads. As a second step, we applied the thresholding 
that was described for R1 tissue libraries.  
While it is plausible that true variants may be lost during thresholding, this method minimized 
false positives as the low count mutants in tissue and virus libraries often seemed to have very 
high enrichment score (as RCs are normalized to input library). In other words, thresholding 
allowed selective investigation on enriched variants that had a higher-confidence in their NGS 
RCs.  
 
 
As an alternative to our manual thresholding method, an optional error correction method called 
“Collapsing” was built to further validate the outcome from filtered datasets. This method starts 
at the lowest count variants (variants of count 1) and searches for potential parent variants that 
are off by one nucleotide but have at least 2-fold higher counts (fold change = (2ΔCT) where CT 
is PCR cycle threshold). This error correction method then transfers the counts of these 
potential erroneous sequences to their originating sequences and repeats recursively until all 
sequences have been considered. On applying this error correction to our thresholded data, an 
additional ~0.002-0.03% of sequences were captured (compared to >19% captured by 
thresholding), confirming that our thresholding strategy was largely successful.  
 
Supplementary Note 27: Estimation of enrichment score for R1 selected variants.  
Since the DNA and virus libraries were not completely sampled unlike the tissue libraries, we 
assigned an estimated RC for variants that were not present in the input library but were present 
in the output library. For instance, R1 virus library is the input library to the R1 tissue libraries. 
The estimated RC is defined as a number that is lower than the lowest RC in the library with the 
assumption that these variants were found at a relatively lower abundance than the variants 
recovered from the deep sequencing. In virus libraries, since RC of 1.0 was the lowest, we 
assigned all missing variants an estimated RC of 0.9. We use this method to calculate the 
enrichment score of the R1 tissue libraries which is normalized to R1 virus library (Fig. 1d). This 
was done to represent libraries across two selection rounds consistently. Although, the 
individual enrichment score among R1 variants didn’t add a significant value to the variants 
selected for R2 selection as described in the criteria to separate signal vs noise in R1 using the 
RCs. 
 
Supplementary Note 28: Heatmap for amino acid bias 
Each heatmap uses both an expected (input) distribution of amino acid sequences and an 
output distribution. The output distribution must be a list of sequences and their count, and the 
input distribution can be either a list of sequences and their count, or an expected amino acid 
frequency from a template, such as NNK. For both input and output, the total count of amino 
acids in each position is tallied in accordance to each sequence's count and then divided by the 
total sum of counts, giving a frequency of each amino acid at each position. Then, the log2 fold 
change is calculated between the output and the input. For amino acids with a count of 0 in 
either the input or output, no calculation is performed. In order to distinguish between 
statistically significant amino acid biases, a statistical test was performed using the statsmodels 
Python library. For the case where there are two amino acid counts, a two-sided, two-proportion 
z-test was performed; for comparing the output amino acid count to an expected input frequency 
from a template, a one-proportion z-test was performed. All p-values were then corrected for 
multiple comparisons using Bonferroni correction. Only bias differences below a significance 
threshold of 1e-4 are then outlined on the heatmap; all other (insignificant) squares are left 
empty. 
 
Supplementary Note 29: Clustering analysis 
 
 
The reverse Hamming distances (representing the number of shared AAs between two 
peptides) was determined for all unique capsid variants with greater than 10 count and greater 
than 2.5-fold enrichment after R2 selection. This process iteratively compares each variant with 
all other variants within the group. Capsid variants were then clustered by their reverse 
Hamming distances using Cytoscape. The minimum reverse Hamming distance for visualization 
was chosen manually based on sequence similarity. 
For the amino acid frequency plots, the number on the bottom represents the position of the 
diversified motif starting from 1. The size of the amino acid in the stack reflects the proportion of 
unique clones in which the AA appears at that specific position in the motif. The color code is 
based on the AA properties. The positively charged residues K, R, and H are in blue. The 
negatively charged residues D and E are in red. The amide containing polar residues Q, and N 
are in magenta. The polar residues T, and S, are in green. The hydrophobic residues A, L, V, I, 
P, F, M, and W are in black. 
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